title: Sphingomyelin Synthase 1 Regulates Neuro-2a Cell Proliferation and Cell Cycle Progression Through Modulation of p27 Expression and Akt Signaling.
abstract: Sphingomyelin synthase (SMS) is a key enzyme involved in the generation of sphingomyelin (SM) and regulation of cell growth and survival. However, the effects of SMS on neuronal cell proliferation and cell cycle progression are not completely elucidated. In this study, we examined the direct effects of SMS1 in regulating cell cycle progression and proliferation of Neuro-2a cells that exhibit neuronal characteristics. Neuro-2a cells transfected with SMS-specific small hairpin RNA (shRNA) expressed significantly lower levels of SMS1. RNA interference-mediated depletion of SMS1 in Neuro-2a cells caused a significant decrease in SM levels. Decreased SMS1 levels resulted in reduced proliferation rate and morphological changes including neurite-like outgrowth. Also, silencing of SMS1 induced cell cycle arrest as shown by the increased percentage of cells in G0/G1 and decreased proportion of cells in S phase. These changes were accompanied by upregulation of cyclin-dependent kinase inhibitor p27 and decreased levels of cyclin D1 and phospho-Akt. Nuclear accumulation of p27 was also evident in SMS1-deficient cells. Furthermore, loss of SMS1 inhibited the migratory potential of Neuro-2a cells in association with decreased levels of matrix metalloproteinases. These results indicate that SMS1 plays an important role in mediating the key signaling pathways that are involved in the tight coordination of multiple cellular activities, including neuronal cell proliferation, cell cycle progression, and migration, and therefore may have significant implications in neurodegenerative diseases.
authors.affiliation: Department of Neurological Surgery, University of Wisconsin, Box 8660 Clinical Science Center, 600 Highland Ave, Madison, WI, 53792, USA, u.wesley@neurosurgery.wisc.edu.
authors.forename: Umadevi V
authors.initials: UV
authors.lastname: Wesley
authors.forename: James F
authors.initials: JF
authors.lastname: Hatcher
authors.forename: Robert J
authors.initials: RJ
authors.lastname: Dempsey
mesh_terms: D000818:Animals; D002453:Cell Cycle / Q000502:physiology*; D002455:Cell Division / Q000502:physiology*; D002460:Cell Line; D049109:Cell Proliferation / Q000502:physiology*; D050760:Cyclin-Dependent Kinase Inhibitor p27 / Q000378:metabolism*; D051379:Mice; D051057:Proto-Oncogene Proteins c-akt / Q000378:metabolism*; D015398:Signal Transduction / Q000502:physiology; D017855:Transferases (Other Substituted Phosphate Groups) / Q000378:metabolism*
chemical_list: C493961:Cdkn1b protein, mouse; D050760:Cyclin-Dependent Kinase Inhibitor p27; D051057:Proto-Oncogene Proteins c-akt; D017855:Transferases (Other Substituted Phosphate Groups); C070186:phosphatidylcholine-ceramide phosphocholine transferase
references.citation: Mol Neurobiol. 2010 Jun;41(2-3):206-17
references.pmid: 20148315
references.citation: Oncogene. 2009 Oct 15;28(41):3652-62
references.pmid: 19648963
references.citation: Med Pediatr Oncol. 2001 Jan;36(1):97-9
references.pmid: 11464914
references.citation: Cereb Cortex. 2011 Aug;21(8):1840-56
references.pmid: 21245411
references.citation: Nat Chem Biol. 2010 Jul;6(7):489-97
references.pmid: 20559316
references.citation: BMC Complement Altern Med. 2013 Oct 11;13:261
references.pmid: 24119256
references.citation: Biochim Biophys Acta. 2007 Sep;1771(9):1186-94
references.pmid: 17616479
references.citation: Nat Med. 2002 Oct;8(10):1136-44
references.pmid: 12244303
references.citation: Mediators Inflamm. 2013;2013:928315
references.pmid: 23840100
references.citation: Adv Exp Med Biol. 2014;800:59-74
references.pmid: 24243100
references.citation: Cancer Cell. 2005 Jan;7(1):51-63
references.pmid: 15652749
references.citation: Front Biosci. 2006 May 01;11:1696-701
references.pmid: 16368548
references.citation: Neuron. 2009 May 14;62(3):312-26
references.pmid: 19447088
references.citation: Genes Dev. 2006 Jun 1;20(11):1511-24
references.pmid: 16705040
references.citation: Mol Neurobiol. 2012 Jun;45(3):455-64
references.pmid: 22415444
references.citation: J Lipid Res. 2013 Mar;54(3):794-805
references.pmid: 23160178
references.citation: Curr Vasc Pharmacol. 2015;13(2):161-6
references.pmid: 24188490
references.citation: J Biol Chem. 2011 Oct 14;286(41):36053-36062
references.pmid: 21856749
references.citation: Cancer Res. 2006 Jan 15;66(2):1062-9
references.pmid: 16424042
references.citation: J Biol Chem. 2006 Oct 6;281(40):29421-5
references.pmid: 16905542
references.citation: Neurochem Res. 2002 Aug;27(7-8):609-17
references.pmid: 12374196
references.citation: Oncogene. 2003 Aug 11;22(33):5208-19
references.pmid: 12910258
references.citation: J Biol Chem. 2007 Jun 15;282(24):17537-47
references.pmid: 17449912
references.citation: FEBS J. 2013 Dec;280(24):6280
references.pmid: 24286187
references.citation: Nat Rev Cancer. 2009 Aug;9(8):550-62
references.pmid: 19629070
references.citation: J Biol Chem. 1998 Jun 5;273(23):14550-9
references.pmid: 9603970
references.citation: Pathol Biol (Paris). 2000 Apr;48(3):203-10
references.pmid: 10858954
references.citation: Mol Cell Biol. 2012 Aug;32(16):3242-52
references.pmid: 22688512
references.citation: Circ Res. 2009 Jul 31;105(3):295-303
references.pmid: 19590047
references.citation: Exp Gerontol. 2013 Jul;48(7):647-53
references.pmid: 23470275
references.citation: J Lipid Res. 2013 May;54(5):1457-65
references.pmid: 23471028
references.citation: Science. 1989 Nov 24;246(4933):1050
references.pmid: 2555921
references.citation: Mol Cancer Ther. 2008 May;7(5):1164-75
references.pmid: 18483304
references.citation: Cancer Res. 2002 Nov 1;62(21):6312-7
references.pmid: 12414662
references.citation: J Cell Biochem. 2003 Jun 1;89(3):539-49
references.pmid: 12761887
references.citation: Nat Med. 2002 Oct;8(10):1145-52
references.pmid: 12244301
references.citation: J Cell Sci. 2013 Jan 15;126(Pt 2):445-53
references.pmid: 23230143
references.citation: Biochem Biophys Res Commun. 2012 Aug 3;424(3):421-6
references.pmid: 22766505
references.citation: Biochem Biophys Res Commun. 2007 Jun 22;358(1):196-202
references.pmid: 17467659
references.citation: Arterioscler Thromb Vasc Biol. 2012 Jul;32(7):1577-84
references.pmid: 22580896
references.citation: J Biol Chem. 2001 Apr 20;276(16):12797-804
references.pmid: 11278937
references.citation: Neuroreport. 2010 Jul 14;21(10):700-3
references.pmid: 20568314
references.citation: Brain Res. 2013 Feb 16;1496:1-9
references.pmid: 23246924
references.citation: Exp Cell Res. 2004 Jan 15;292(2):385-92
references.pmid: 14697345
references.citation: Trends Cell Biol. 2003 Feb;13(2):65-70
references.pmid: 12559756
references.citation: Cell Cycle. 2009 Nov 1;8(21):3455-61
references.pmid: 19829074
references.citation: J Lipid Res. 2008 Feb;49(2):376-85
references.pmid: 17982138
references.citation: Biochim Biophys Acta. 2014 May;1841(5):692-703
references.pmid: 24355909
references.citation: Dev Cell. 2008 Feb;14(2):159-69
references.pmid: 18267085
references.citation: Future Oncol. 2010 Oct;6(10):1603-24
references.pmid: 21062159
references.citation: EMBO Rep. 2004 Aug;5(8):777-82
references.pmid: 15289826
references.citation: Biochemistry. 2001 Apr 24;40(16):4893-903
references.pmid: 11305904
references.citation: Trends Mol Med. 2007 Aug;13(8):327-36
references.pmid: 17588815
references.citation: Clin Dev Immunol. 2013;2013:309302
references.pmid: 24078816
references.citation: Neurochem Res. 2012 Apr;37(4):671-9
references.pmid: 22101393
references.citation: J Biol Chem. 2006 Nov 3;281(44):33606-20
references.pmid: 16893893
references.citation: Nat Med. 2002 Oct;8(10):1153-60
references.pmid: 12244302
references.citation: Development. 2013 Aug;140(15):3079-93
references.pmid: 23861057
references.citation: Exp Cell Res. 2008 May 1;314(8):1860-8
references.pmid: 18374917